Literature DB >> 9409571

Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study.

J C Mendes de Almeida1, P Chaves, A D Pereira, N K Altorki.   

Abstract

OBJECTIVE: To obtain biochemical evidence that Barrett's esophagus (BE) is the precursor of most adenocarcinomas (Adc) of the esophagus and cardia. SUMMARY BACKGROUND DATA: Based on morphologic data, BE was previously proposed as the precursor of most Adc of the esophagus. This hypothesis would receive strong support if biochemical evidence were found to demonstrate a pattern common to BE and Adc of the esophagus and cardia.
METHODS: We studied the presence of intestinal-type proteins sucrase-isomaltase (SI) and crypt Cell Antigen (CCAg) in BE, Barrett's Adc, and esophageal-cardial Adc without BE. In each case specimens were collected from normal esophagus, stomach, tumor, and BE mucosa when present. To study related conditions, five specimens of peptic esophagitis and of squamous cell carcinoma were also analyzed. An indirect immunofluorescence technique was employed and sections were analyzed with laser confocal microscopy imaging.
RESULTS: Most Barrett's mucosa specimens stained positively for SI (93%) and CCAg (89%). These proteins were detected in BE independently of the type of metaplasia, the coexistence of dysplasia, or the presence of associated Adc. SI and CCAg were present in 25 (96%) and 24 (92%) of the cases of Adc respectively. No statistical difference was detected in SI and CCAg expression between Adc samples with and without BE, between BE and Adc samples with or without BE, and between tumors located in the esophagus versus the cardia. No staining for these proteins was detected in stomach or esophageal mucosa, in submucosal glands of the esophagus, in peptic esophagitis or squamous cell carcinoma.
CONCLUSION: These data show that BE and Adc of the esophagus and cardia have a similar phenotype and support the hypothesis that most of these tumors probably originate from preexisting BE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409571      PMCID: PMC1191146          DOI: 10.1097/00000658-199712000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  37 in total

1.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus.

Authors:  B J Reid; R C Haggitt; C E Rubin; G Roth; C M Surawicz; G Van Belle; K Lewin; W M Weinstein; D A Antonioli; H Goldman
Journal:  Hum Pathol       Date:  1988-02       Impact factor: 3.466

2.  Changing distribution of adenocarcinoma of the stomach.

Authors:  I M Paterson; D F Easton; C M Corbishley; J C Gazet
Journal:  Br J Surg       Date:  1987-06       Impact factor: 6.939

3.  Crypt cell antigen expression in human colon tumor cell lines: analysis with a panel of monoclonal antibodies to CaCo-2 luminal membrane components.

Authors:  A Quaroni
Journal:  J Natl Cancer Inst       Date:  1986-04       Impact factor: 13.506

Review 4.  Barrett's esophagus.

Authors:  M K Ferguson; A G Little; D B Skinner
Journal:  Adv Surg       Date:  1988

5.  Immunohistological evidence, obtained with monoclonal antibodies, of small intestinal brush border hydrolases in human colon cancers and foetal colons.

Authors:  A Zweibaum; H P Hauri; E Sterchi; I Chantret; K Haffen; J Bamat; B Sordat
Journal:  Int J Cancer       Date:  1984-11-15       Impact factor: 7.396

6.  Fetal characteristics of small intestinal crypt cells.

Authors:  A Quaroni
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

7.  Barrett's esophagus. Comparison of benign and malignant cases.

Authors:  D B Skinner; B C Walther; R H Riddell; H Schmidt; C Iascone; T R DeMeester
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

8.  Cancer of the distal esophagus and cardia. Incidence, tumorous infiltration, and metastatic spread.

Authors:  H U Sons; F Borchard
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

9.  Expression of developmentally regulated crypt cell antigens in human and rat intestinal tumors.

Authors:  A Quaroni; M M Weiser; S Lee; D Amodeo
Journal:  J Natl Cancer Inst       Date:  1986-08       Impact factor: 13.506

10.  Study of intestinal cell differentiation with monoclonal antibodies to intestinal cell surface components.

Authors:  A Quaroni; K J Isselbacher
Journal:  Dev Biol       Date:  1985-10       Impact factor: 3.582

View more
  12 in total

1.  Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus.

Authors:  J Theisen; H J Stein; H J Dittler; M Feith; C Moebius; W K H Kauer; M Werner; J R Siewert
Journal:  Surg Endosc       Date:  2002-01-09       Impact factor: 4.584

Review 2.  Barrett's esophagus: environmental influences in the progression of dysplasia.

Authors:  Ralph A Boulton; Bernhard Usselmann; Imtiyaz Mohammed; Janusz Jankowski
Journal:  World J Surg       Date:  2003-07-28       Impact factor: 3.352

Review 3.  Cancer of the esophagogastric junction: epidemiology and pathogenesis.

Authors:  Prateek Sharma
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

4.  Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery.

Authors:  S Oberg; J Johansson; J Wenner; F Johnsson; T Zilling; C S von Holstein; J Nilsson; B Walther
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

Review 5.  Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy.

Authors:  S R DeMeester; T R DeMeester
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

Review 6.  Pathophysiology and treatment of Barrett's esophagus.

Authors:  Daniel S Oh; Steven R Demeester
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

7.  Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.

Authors:  C J Buskens; A Sivula; B P van Rees; C Haglund; G J A Offerhaus; J J B van Lanschot; A Ristimäki
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

8.  Esophagectomy for adenocarcinoma in patients 45 years of age and younger.

Authors:  J Scott Bolton; T T Wu; C J Yeo; J L Cameron; R F Heitmiller
Journal:  J Gastrointest Surg       Date:  2001 Nov-Dec       Impact factor: 3.452

9.  Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus.

Authors:  Yuri V Bobryshev; Dinh Tran; Murray C Killingsworth; Michael Buckland; Reginald V N Lord
Journal:  J Gastrointest Surg       Date:  2008-11-18       Impact factor: 3.452

Review 10.  Current management of Barrett esophagus and esophageal adenocarcinoma.

Authors:  Tavankit Singh; Vedha Sanghi; Prashanthi N Thota
Journal:  Cleve Clin J Med       Date:  2019-11       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.